908 results on '"Okugawa, Yoshinaga"'
Search Results
202. Identification of Predictors of Recurrence in Patients with Lower Rectal Cancer Undergoing Neoadjuvant Chemotherapy: A Direct Comparison of Short-Course and Long-Course Chemoradiotherapy
203. Clinical burden of prognostic nutrition index in patients with rectal cancer who receive preoperative chemoradiotherapy
204. Risk factors and measures of pulmonary complications after thoracoscopic esophagectomy for esophageal cancer
205. Identification of Predictors of Recurrence in Patients with Lower Rectal Cancer Undergoing Neoadjuvant Chemotherapy: A Direct Comparison of Short-Course and Long-Course Chemoradiotherapy
206. Comprehensive analysis identifying aberrant DNA methylation in rectal mucosa from ulcerative colitis patients with neoplasia
207. Downregulation of trefoil factor‑3 expression in the rectum is associated with the development of ulcerative colitis‑associated cancer
208. Abstract 2958: Development of a superenhancer element-associated transcription factor signature in primary tumors for the identification of liver metastasis in colorectal cancer patients
209. Abstract 1066: L1CAM as a pivotal mediator for disease progression and prognostic biomarker in gastric cancer patients
210. AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer
211. Reply
212. Colony-stimulating factor-1 and colony-stimulating factor-1 receptor co-expression is associated with disease progression in gastric cancer
213. Clinical Impact of Muscle Quantity and Quality in Colorectal Cancer Patients: A Propensity Score Matching Analysis
214. Mo1979 - Tissue and Serum PD-L1 Expression as a Predictive Biomarker, Early Recurrence and Prognosis in Gastric Cancer Patients
215. Mo1977 - Lymphocyte-C-Reactive Protein Ratio as a New Promising Predictive Marker for Surgical and Oncological Outcome in CRC Patients
216. Tu1948 - Poorly Differentiated Clusters High Grade is Associated with Poor Prognosis in Colorectal Cancer
217. Re: Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study
218. Prognostic impact of sarcopenia and its correlation with circulating miR-21 in colorectal cancer patients
219. α-Galactosidase A activity modulates DNA methylation of androgen receptor promoter in Fabry disease endothelial cells
220. A RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer
221. Feasibility of Assessing Prognostic Nutrition Index in Patients With Rectal Cancer Who Receive Preoperative Chemoradiotherapy
222. Clinical Impact of Preoperative Albumin-Globulin Ratio in Patients with Rectal Cancer Treated with Preoperative Chemoradiotherapy
223. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer
224. FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer
225. Clinical burden of preoperative albumin-globulin ratio in esophageal cancer patients
226. 直腸癌に対する化学放射線療法の最適化 : エピジェネティックスの導入による新展開
227. Successful identification of a predictive biomarker for lymph node metastasis in colorectal cancer using a proteomic approach
228. Fish oil-enriched nutrition combined with systemic chemotherapy for gastrointestinal cancer patients with cancer cachexia
229. Abstract 3367: The clinical significance of epigenetic microRNA-137 silencing in patients with ulcerative colitis
230. Abstract 1795: Hypermethylation status of PDX1 has potential of diagnostic and predictive biomarker for risk stratification in colorectal cancer patients
231. Abstract 3356: Novel evidence for AZIN1 RNA editing-mediated oncogenic role in colorectal cancer
232. Abstract 4720: Novel findings for the clinical significance of RNA editing status of AZIN1 and ADAR 1 and 2 expression levels in gastric cancer patients
233. N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration
234. Emerging Role of MicroRNAs as Liquid Biopsy Biomarkers in Gastrointestinal Cancers
235. EPA-Enriched Nutrition as a Combined Modality Therapy for Cachectic Cancer Patients Undergoing Systemic Chemotherapy in Gastrointestinal Cancer
236. Identification of a Mirna Cluster with Prognostic Biomarker Potential in Colorectal Cancer
237. Exportin-5 Functions as an Oncogene and a Potential Therapeutic Target in Colorectal Cancer
238. Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis
239. Preoperative evaluation of heat shock protein 47 expression to identify patients with colorectal cancer with lymph node metastasis and poor prognosis.
240. Clinical Impact of the AKT1 rs1130233 SNP in Japanese Gastrointestinal Cancer Patients with Palliative Care
241. A Case of Metastatic Axillary Adenocarcinoma of Unknown Primary Site Suggestive of Granulocyte-colony Stimulating Factor Production
242. Objective Predictive Score as a Feasible Biomarker for Short-term Survival in TerminalIy Ill Patients with Cancer
243. MicroRNA-7 Is Associated with Malignant Potential and Poor Prognosis in Human Colorectal Cancer
244. Advanced Lung Cancer Inflammation Index Predicts Outcomes of Patients With Colorectal Cancer After Surgical Resection
245. Possibility of limited gastrectomy for early gastric cancer located in the upper third of the stomach, based on the distribution of sentinel node basins.
246. Close Relationship Between Immunological/Inflammatory Markers and Myopenia and Myosteatosis in Patients With Colorectal Cancer: A Propensity Score Matching Analysis.
247. Phase I study of preoperative chemoradiotherapy with sequential oxaliplatin and irinotecan with S-1 for locally advanced rectal cancer.
248. Soluble PD-L1 Expression in Circulation as a Predictive Marker for Recurrence and Prognosis in Gastric Cancer: Direct Comparison of the Clinical Burden Between Tissue and Serum PD-L1 Expression.
249. Risk factors and measures of pulmonary complications after thoracoscopic esophagectomy for esophageal cancer.
250. Identification of Predictors of Recurrence in Patients with Lower Rectal Cancer Undergoing Neoadjuvant Chemotherapy: A Direct Comparison of Short-Course and Long-Course Chemoradiotherapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.